Osteoconductive Implants and Methods of Using Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 13/250,096, filed Sep 30, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,517,902 | Expandable Amnion Membrane for Treating Non-Healing Wounds In force · Medium confidence | Prime Merger Sub, LLC | In force | Medium confidence | ||
| US 9,486,316 | Osteoconductive Implants and Methods of Using Same In force · High confidence | Prime Merger Sub, LLC | In force | High confidence | ||
| US 9,539,104 | Osteoconductive Implants and Methods of Using Same In force · High confidence | Prime Merger Sub, LLC | In force | High confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.